Premium-grade Cholic Acid series products optimized for the Los Angeles biotech & clinical research sector.
Essential lipid component and stabilizer engineered for liposomal formulation development and cell culture media applications in California.
Read Details
Ultra-pure metabolic marker pigment designed for diagnostic control kits, liver function assays, and translational biochemistry research.
Read Details
Standard unconjugated bile acid acting as an indispensable micellar surfactant for oral bioavailability enhancement of poorly soluble APIs.
Read Details
Highly sought FXR agonist primary bile acid, manufactured in GMP lines to support drug research in metabolic pathways and cellular transport.
Read DetailsCholic acid (3α,7α,12α-trihydroxy-5β-cholan-24-oic acid) and its associated derivatives represent a foundational class of steroid-based molecules known collectively as bile acids. In human and veterinary medicine, these biomolecules serve critical physiological roles, primarily acting as signaling hormones via nuclear receptor activation (such as the Farnesoid X Receptor, FXR) and as powerful biological detergents that facilitate micellar solubilization of lipids and fat-soluble vitamins in the intestine. Beyond physiology, the synthetic and pharmaceutical application of these compounds has surged, positioning them as essential excipients and APIs in cutting-edge pharmaceutical formulations.
The Los Angeles metropolitan area—spanning major academic and clinical institutions from UCLA and USC to industrial biotech centers in Thousand Oaks, Pasadena, and El Segundo—houses one of the world's most dynamic life science ecosystems. Research and development entities within this region focus heavily on innovative oncology therapies, metabolic disease research, and advanced drug delivery mechanisms. Cholic acid derivatives are increasingly utilized here as permeation enhancers for oral peptide delivery, stabilizers in vaccine adjuvants, and raw materials for the manufacturing of diagnostic control matrices (e.g., cholesterol and bilirubin standards used in clinical pathology labs across California).
Furthermore, local drug manufacturers require compliance with strict regulatory pathways. Whether developing custom liposomes or synthesizing new chemical entities, these laboratories demand materials that not only meet USP/EP pharmacopeial specifications but also come supported by comprehensive quality documentation, including raw material traceability and impurity profiling. Our specialized supply chain solutions are custom-engineered to meet this exact local demand, minimizing batch-to-batch variation and assuring continuous compliance with California’s stringent biopharmaceutical regulatory standards.
We provide comprehensive supply solutions optimized for the specific challenges of Southern California procurement officers:
A global leader in high-purity natural extracts and biopharmaceutical materials, serving the international market since 2012.
Advanced purification methodologies, synthetic optimization, and green chemistry pathways driving next-generation bile acid manufacturing.
Procurement of bovine and porcine bile from disease-free, veterinary-certified facilities. Strict exclusion of contaminants at the starting block ensures safety against viral and prion agents.
High-throughput preparative chromatography resolves structural isomers, separating cholic acid from deoxycholic and chenodeoxycholic residues with precision resolution.
Coupling of purified bile acids with taurine or glycine under mild, optimized peptide-coupling environments, resulting in highly crystalline, low-impurity sodium salts.
Precision micronization and air-jet milling under sterile cleanrooms (Class D / ISO 8) to supply customized particle size distributions tailored for specific formulation matrices.
Looking ahead, the industry is transitioning toward bio-based and biocatalytic synthesis routes to bypass animal sourcing completely. Our R&D division is heavily invested in engineered enzyme systems capable of converting phytosterols into high-purity bile acids. This biotransformation roadmap will align future manufacturing with global sustainability goals, reducing ecological footprints while offering animal-free, chemically identical cholic acid series products to meet the progressive ethical requirements of Los Angeles' advanced biomedical laboratories.
Our production facility operating under Chengdu Chenlv Herb operates in strict conformance with global standards:
Operating a state-of-the-art facility in Southwest China allows Chengdu Chenlv Herb to merge natural resource accessibility with advanced automation technology. Our "Factory 4.0" initiative integrates Distributed Control Systems (DCS) and SCADA systems across all extraction and isolation steps. Real-time sensor networks continuously track parameters such as pH, solvent concentration, crystallization temperature, and pressure. This digital oversight ensures that every industrial batch conforms to tight standard deviation parameters, minimizing quality fluctuations.
For procurement directors in Los Angeles, this setup delivers a dual advantage: unmatched batch-to-batch consistency and high cost-efficiency. Our automated operations reduce manual material handling, minimizing contamination risks while optimizing solvent recovery rates (often exceeding 95%). Furthermore, we maintain strategic safety stock programs in partnership with West Coast logistics hubs, mitigating supply chain disruptions caused by oceanic shipping delays. When you source from Chenlv Herb, you secure a reliable pipeline of critical chemical intermediates backed by a digital trail of compliance certificates, HPLC chromatograms, and heavy metals analyses.
Why lead innovators choose Chenlv Herb as their long-term supply partner for critical bile acid chemical components.
Continuous R&D focused on synthesizing rare bile derivatives, customizing crystallization polymorphic structures, and enhancing chemical purity beyond standard pharmacopeia levels.
Automated manufacturing processes coupled with direct raw materials sourcing enables us to provide highly competitive global pricing models without sacrificing quality or purity.
West Coast operations support, featuring clear import clearance documents, dedicated account managers, and rapid 24-hour response cycles to keep your research pipelines moving.
Broad physiological profiles of Cholic Acid compounds allow implementation across multiple scientific disciplines.
Providing essential lipids and conjugated bile salts used in dietary formulations focused on supporting natural digestion and metabolic pathways.
Utilized as key starting materials (KSM) for structural modification or as inactive excipients optimizing solubility of complex APIs.
Acting as gentle biosurfactants and emulsifiers in dermatological formulations, promoting active ingredient skin penetration.
Engineered to optimize fat emulsification in precision veterinary feeds, supporting performance and cellular health metrics.
A streamlined workflow from initial communication to Los Angeles delivery validation.
Initial analysis of technical specs, purity grades, and delivery deadlines.
Direct factory pricing structure based on required batch sizes.
Signing agreements including clear terms on purity profiles.
Provision of lab-scale batch samples for testing and chromatographic analysis.
GMP batch runs utilizing DCS automation pathways.
Release testing via HPLC, GC-MS, and endotoxin analysis.
Direct delivery to Southern California warehousing arrays.
A comprehensive portfolio of Cholic Acid derivatives and salts available for commercial-scale supply to the Southern California market.
Unfractionated, natural bile acid extract containing native concentrations of cholic, deoxycholic, and chenodeoxycholic acids for research.
Read Details
Taurine-conjugated derivative of chenodeoxycholic acid, critical for investigation into signal transduction pathways and hepatoprotection.
Read Details
Water-soluble conjugate salt ideal for cell culture and metabolic modeling studies. Prepared under rigorous control standards.
Read Details
A key hydrophilic bile acid with significant therapeutic application in protein folding chaperone research and endoplasmic reticulum stress inhibition.
Read Details
Highly refined water-soluble TUDCA sodium salt, prepared with minimal residual solvent profile for advanced diagnostic systems.
Read Details
Pure conjugated bile salt derivative widely used in biochemical pathways to research intestinal absorption models and cellular lipid transport.
Read Details
Crystalline hydrate compound suited for dry formulation mixing, optimizing stability and dissolving kinetics in research-grade systems.
Read Details
Semisynthetic tri-keto bile acid derivative acting as an effective hydrocholeretic agent, purified to exceed standard industry benchmarks.
Read DetailsCritical insights regarding raw material origin, quality assurance, regulatory alignment, and logistics protocols.
Our Cholic Acid derivatives are primarily utilized as critical raw materials in the synthesis of active pharmaceutical ingredients (APIs), including Ursodeoxycholic Acid (UDCA) and Obeticholic Acid. They also serve as key components in biochemical diagnostic test kits, molecular biology reagents, and as micellar drug delivery vehicles (such as liposomal formulations) to enhance the dissolution rates of hydrophobic drugs.
We leverage High-Performance Liquid Chromatography coupled with Charged Aerosol Detection (HPLC-CAD) or Evaporative Light Scattering Detection (HPLC-ELSD), as bile acids lack strong chromophores for standard UV detection. Additionally, we run Gas Chromatography-Mass Spectrometry (GC-MS) profiles to monitor residual solvents and ensure trace impurities (such as related bile acid monomers) fall below 0.5%.
Currently, the majority of our commercial-scale Cholic Acid series compounds are derived from high-quality animal bile (bovine and porcine), which undergoes extraction in certified facilities with full veterinary and phytosanitary traceability. We also maintain a research development pipeline for plant-derived or biosynthesized alternatives to assist clients requiring non-animal source materials.
We provide comprehensive data packs including detailed Certificates of Analysis (COA), Method of Analysis (MOA) validations, residual solvent statements (in compliance with ICH Q3C limits), BSE/TSE declaration certificates, and complete process flowcharts. For qualified pharmaceutical programs, we can coordinate the drafting and reference of Drug Master Files (DMFs).
Yes. Utilizing advanced jet-milling and micronization technologies, we can tailor the particle size distribution (D10, D50, D90) to match your manufacturing requirements. This is particularly valuable for oral solid dosage formulations, where dissolution rates are highly dependent on specific surface area profiles.
We utilize temperature-controlled cargo containers and high-barrier, multi-layered aluminum packaging to guard against moisture absorption and thermal fluctuations during transit. All shipments destined for California undergo complete validation testing before departure, and temperature dataloggers are embedded in the shipping cartons for batch assurance.
For inventory items currently held in our warehouses, dispatch can occur within 2-3 business days. For customized GMP production campaigns, typical synthesis-to-delivery cycles run between 6 to 8 weeks, inclusive of rigorous internal quality validation and international custom clearance routing through the Port of Los Angeles.
Yes. Our manufacturing infrastructure is designed to scale dynamically. We can synthesize small clinical phase validation batches (1kg to 10kg) with the exact same process controls used for commercial-scale bulk runs (100kg+), ensuring consistency throughout your clinical development lifecycle.
Chenlv Herb